Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01172327
Other study ID # Pro00004658
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 2009
Est. completion date July 2012

Study information

Verified date April 2021
Source University of South Carolina
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to examine the effectiveness and safety of a self-directed physical activity program relative to a self-directed dietary program in adults with arthritis. A process evaluation will also be conducted to examine program reach, participation/dose, fidelity, and participant compatibility/satisfaction.


Description:

Physical activity is a critical component of arthritis disease management. It also reduces the risk for other chronic comorbid conditions in people with arthritis. Yet, most adults with arthritis are not sufficiently active at the level needed to achieve benefits. Existing group-based arthritis exercise programs reach only a very small percentage of the population. The overall purpose of this study is to test a self-directed and low-cost multicomponent physical activity program for people with arthritis on outcomes including symptoms of arthritis, lower body strength, functional aerobic capacity, flexibility, physical activity, arthritis self-efficacy and disability, upper body strength, balance, gait, and depressive symptoms. The second primary aim is to evaluate the safety of the physical activity program. The third primary aim is to conduct a process evaluation to examine program reach, participation/dose, fidelity, and participant compatibility/satisfaction. Adults aged 18 years and older with arthritis will be recruited from the midlands area of South Carolina. After completion of a baseline visit, participants will be randomized in equal numbers to the 12-week physical activity program (First Step to Active Health®) or the 12-week attention-control group (Steps to Healthy Eating). The attention control intervention will have the same "look and feel" as the physical activity intervention and will require similar activities such as self-monitoring of behavior. Follow-up measurements will take place post-program (12-weeks) and 6 months post-program (i.e., 9 months post-randomization). If First Step to Active Health® is shown to be effective, it could be widely disseminated for a very low cost, thus having the potential to make a tremendous public health impact on the burden of arthritis.


Recruitment information / eligibility

Status Completed
Enrollment 401
Est. completion date July 2012
Est. primary completion date July 2012
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Self-reported, health care provider-diagnosed arthritis (CDC definition) - 18+ years of age - Self-reported symptoms of joint pain, stiffness, tenderness, decreased range of motion, redness and warmth, deformity, crackling or grating, or fatigue - Able to read and write in English Exclusion Criteria: - Another member of household is participating in study - Plans to move from the Columbia, SC area in the next 9 months - Unable to walk longer than 3 minutes without taking a rest - Unable to stand without assistance for more than 2 minutes - Cannot sit in a chair without arms for more than 5 minutes - Measured resting blood pressure >160/100 - Positive response to PAR-Q question(s) - Had a fall in the past year that required medical assistance - Pregnant or breastfeeding - Uses insulin to manage diabetes - Participating in another research study that includes an intervention or drug - Participates in 3+ days of structured moderate-intensity exercise for 30+ minutes per day - Participates in 2+ days of strength building exercises for 20+ minutes per day

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Multicomponent exercise
This intervention is a self-directed, multicomponent, exercise intervention. Participants exercise on their own and follow a progressive stepped program that occurs in the following order: cardiorespiratory exercises, flexibility exercises, strength (upper and lower body) exercises, and balance exercises. Participants also complete a daily log of their exercises and return the logs every week for 12 weeks. The active intervention phase is 12 weeks.
Nutrition
This arm is a self-directed nutrition intervention. Participants follow a progressive stepped program that occurs in the following order: fruits, vegetables, grains, meat and beans. Participants also complete a daily log of their dietary intake and return the logs every week for 12 weeks. The active intervention lasts for 12 weeks.

Locations

Country Name City State
United States University of South Carolina Prevention Research Center Columbia South Carolina

Sponsors (2)

Lead Sponsor Collaborator
University of South Carolina Centers for Disease Control and Prevention

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Symptoms of arthritis Visual numeric scales to assess pain, fatigue, and stiffness 12 weeks
Primary Lower body strength The 30-second chair stand will assess lower body strength. 12 weeks
Primary Functional exercise capacity The six-minute walk will assess functional exercise capacity 12 weeks
Primary Flexibility The sit-and-reach test will assess flexibility 12 weeks
Primary Physical activity The Community Health Activities Model Program for Seniors Physical Activity (CHAMPS) Questionnaire will assess physical activity participation 12 weeks
Primary Arthritis management self-efficacy The Arthritis Self-Efficacy Scale will assess confidence in managing arthritis symptoms 12 weeks
Secondary Disability The Health Assessment Questionnaire (HAQ) will assess disability 12 weeks
Secondary Upper body strength The grip strength test (kg/lbs of force) will assess upper body strength 12 weeks
Secondary Balance Postural sway will be measured with the AMTI force platform to determine COP displacement, COP velocity, and 95th eclipse 12 weeks
Secondary Gait GAITRite will assess components of gait including cadence, step time, cycle time, step length, stride length, and velocity 12 weeks
Secondary Depressive symptoms The short form of the Center for Epidemiological Studies Depression scale (CES-D) will assess depressive symptoms 12 weeks
See also
  Status Clinical Trial Phase
Completed NCT04226131 - MusculRA: The Effects of Rheumatoid Arthritis on Skeletal Muscle Biomechanics N/A
Completed NCT04171414 - A Study to Evaluate Usability of Subcutaneous Auto-injector of CT-P17 in Patients With Active Rheumatoid Arthritis Phase 3
Completed NCT02833350 - Safety and Efficacy Study of GDC-0853 Compared With Placebo and Adalimumab in Participants With Rheumatoid Arthritis (RA) Phase 2
Completed NCT04255134 - Biologics for Rheumatoid Arthritis Pain (BIORA-PAIN) Phase 4
Recruiting NCT05615246 - Exactech Humeral Reconstruction Prosthesis of Shoulder Arthroplasty PMCF (HRP)
Completed NCT03248518 - Lessening the Impact of Fatigue in Inflammatory Rheumatic Diseases N/A
Completed NCT03514355 - MBSR in Rheumatoid Arthritis Patients With Controlled Disease But Persistent Depressive Symptoms N/A
Recruiting NCT06005220 - SBD121, a Synbiotic Medical Food for RA Management N/A
Recruiting NCT05451615 - Efficacy and Safety of Abatacept Combined With JAK Inhibitor for Refractory Rheumatoid Arthritis Phase 3
Completed NCT05054920 - Eccentric Versus Concentric Exercises for Rotator Cuff Tendinopathy in Patients With Rheumatoid Arthritis N/A
Completed NCT02037737 - Impact and Use of Abatacept IV for Rheumatoid Arthritis in Real Life Setting N/A
Recruiting NCT04079374 - Comparative Efficacy, Safety and Immunogenicity Study of Etanercept and Enbrel Phase 3
Completed NCT02504268 - Effects of Abatacept in Patients With Early Rheumatoid Arthritis Phase 3
Recruiting NCT05496855 - Remote Care in People With Rheumatoid Arthritis N/A
Completed NCT05051943 - A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic Response
Recruiting NCT06031415 - Study of GS-0272 in Participants With Rheumatoid Arthritis Phase 1
Recruiting NCT06103773 - A Study of Single and Multiple Oral Doses of TollB-001 Phase 1
Completed NCT05999266 - The Cartilage and Muscle Thickness on Knee Pain in Patients With Rheumatoid Arthritis
Recruiting NCT05302934 - Evaluation of the PHENO4U Data Platform in Patients Undergoing Total Knee Arthroplasty
Recruiting NCT04169100 - Novel Form of Acquired Long QT Syndrome Phase 4